Back to Search
Dossier
一种包含GPC3靶向多肽和GalNac-FBXL6 siRNA的组合物及其应用
InventionUnknown
8Claims · 1 independent
§ Ⅰ
Dossier Overview
Inventor
谢传明; 林晓彤; 张捷; 吴迪; 毛毳; 朱贞宝; 方蕾
Filing Date
Aug 19, 2026
Publication Date
Oct 27, 2026
IPC Classification
A61K 47/64 (2017.01)A61K 31/713 (2006.01)A61P 1/16 (2006.01)A61P 29/00 (2006.01)A61P 35/00 (2006.01)
本发明属于生物医药技术领域,提供了一种包含GPC3靶向多肽和GalNac‑FBXL6 siRNA的组合物及其应用,将包含GPC3靶向多肽和GalNac‑FBXL6 siRNA的组合物用于提高GalNac‑FBXL6 siRNA对肝脏病变细胞(包括GPC3阳性的肝癌细胞及炎性病变肝细胞)的靶向性和摄取效率,实现GPC3多肽与FBXL6 siRNA的协同抗肝脏疾病作用,从而提供一种更安全、更有效的肝脏疾病联合治疗策略,特别是用于肝炎、肝纤维化、肝硬化或肝细胞癌的治疗。
Sign in to read the full text
Claim 1 is shown. Create a free account to read all 8 claims, the full description, all drawings, translations and legal status.
- All claims
- Technical field
- Background
- Summary
- Drawing descriptions
- Detailed description
External Resources